ArticleJournal of clinical microbiology2006
Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species.
Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- A Rare Manifestation of Mycobacterium kansasii as a Cutaneous Infection: A Case Report.Cureus · 2026Article
- One-step multiplex PCR assay for identification ofMicrobiology spectrum · 2026Article
- Evaluation of the GenoType Mycobacterium CM/AS Assay for Species Identification of Mycobacteria.Cureus · 2025Article
- Review
- Article
- Article
- Evaluation of the MeltPro Myco Assay for the Identification of Non-Tuberculous Mycobacteria.Infection and drug resistance · 2022Article
- Cas12a/Guide RNA-Based Platform for Rapid and Accurate Identification of MajorJournal of clinical microbiology · 2020Article
- Non-tuberculous Mycobacteria can Cause Disseminated Mycobacteriosis in Cats.Journal of comparative pathology · 2018Article
- Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria.Current infectious disease reports · 2018Review
- Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.BMC infectious diseases · 2017Article
- Evaluation of GenoType NTM-DR Assay for Identification of Mycobacterium chimaera.Journal of clinical microbiology · 2017Article
- Mycobacterium marinum.Microbiology spectrum · 2017Review
- Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease.Epidemiology and infection · 2017Article
- Diagnosis of active tuberculosis disease: From microscopy to molecular techniques.Journal of clinical tuberculosis and other mycobacterial diseases · 2016Review
- Abattoir-based estimates of mycobacterial infections in Cameroon.Scientific reports · 2016Article
- Molecular Mycobacteriology and Expansion in Disease Diagnosis.Indian journal of clinical biochemistry : IJCB · 2016Review
- The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China.PLoS neglected tropical diseases · 2015Article
- Mixed Cutaneous Infection Caused by Mycobacterium szulgai and Mycobacterium intermedium in a Healthy Adult Female: A Rare Case Report.Case reports in dermatological medicine · 2015Article
- Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.Journal of clinical microbiology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The new commercial assay GenoType Mycobacterium, intended for the identification of mycobacteria, was evaluated with a panel of 197 strains belonging to 86 different taxa. The system, which relies on solid-phase reverse hybridization, is composed of two different kits: GenoType CM for the identification of more frequently detected mycobacterial species and GenoType AS for less common species. The sensitivity and specificity were 97.9% and 92.4% for the CM kit and 99.3% and 99.4% for the AS kit. Our results show that the system may represent a useful tool to substantially enlarge the number of mycobacteria that can be reliably identified in clinical laboratories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.